Related references
Note: Only part of the references are listed.Fragile X Mice: Reduced Long-Term Potentiation and N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Dentate Gyrus
Sung Hwan Yun et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
Moustapha Cisse et al.
NATURE (2011)
Lipid raft disruption protects mature neurons against amyloid oligomer toxicity
Fiorella Malchiodi-Albedi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Prion protein and Aβ-related synaptic toxicity impairment
Anna Maria Calella et al.
EMBO MOLECULAR MEDICINE (2010)
Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice
Corinne G. Jolivalt et al.
EXPERIMENTAL NEUROLOGY (2010)
Cholesterol and statins in Alzheimer's disease: Current controversies
Ana Catarina R. G. Fonseca et al.
EXPERIMENTAL NEUROLOGY (2010)
Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption
Wei-Qin Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers ROLE OF N-TERMINAL RESIDUES
Shugui Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane
Mariagioia Zampagni et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
David A. Gimbel et al.
JOURNAL OF NEUROSCIENCE (2010)
A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo
Takami Tomiyama et al.
JOURNAL OF NEUROSCIENCE (2010)
The prion protein as a receptor for amyloid-β Reply
Juha Lauren et al.
NATURE (2010)
The prion protein as a receptor for amyloid-β
Helmut W. Kessels et al.
NATURE (2010)
Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons
P. J. Shughrue et al.
NEUROBIOLOGY OF AGING (2010)
Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease
Akihiko Nunomura et al.
NEUROBIOLOGY OF DISEASE (2010)
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Marianne Renner et al.
NEURON (2010)
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
Shuko Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Claudia Balducci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The formation of acetylcholine receptor clusters visualized with quantum dots
Lin Geng et al.
BMC NEUROSCIENCE (2009)
Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
Wei-Qin Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Amyloid-β Membrane Binding and Permeabilization are Distinct Processes Influenced Separately by Membrane Charge and Fluidity
Pamela T. Wong et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses
Atul Deshpande et al.
JOURNAL OF NEUROSCIENCE (2009)
The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo
Juliet K. Knowles et al.
JOURNAL OF NEUROSCIENCE (2009)
Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory Behaviors
David R. Marks et al.
JOURNAL OF NEUROSCIENCE (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease
Summer L. Bernstein et al.
NATURE CHEMISTRY (2009)
Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
Shaomin Li et al.
NEURON (2009)
Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Yazi D. Ke et al.
PLOS ONE (2009)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
Fernanda G. De Felice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Jae-Eun Kang et al.
SCIENCE (2009)
A new amyloid μ variant favoring oligomerization in Alzheimer's-type dementia
Takami Tomiyama et al.
ANNALS OF NEUROLOGY (2008)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders
F. Rahimi et al.
CURRENT ALZHEIMER RESEARCH (2008)
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Wei-Qin Zhao et al.
FASEB JOURNAL (2008)
Structural Classification of Toxic Amyloid Oligomers
Charles G. Glabe
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Amyloid-β binds to the extracellular cysteine-rich domain of frizzled and inhibits wnt/β-catenin signaling
Margaret H. Magdesian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice
Anne Eckert et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity
Emmanuel Sturchler et al.
JOURNAL OF NEUROSCIENCE (2008)
Defective Insulin Signaling Pathway and Increased Glycogen Synthase Kinase-3 Activity in the Brain of Diabetic Mice: Parallels With Alzheimer's Disease and Correction by Insulin
C. G. Jolivalt et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo
Shu-Ling Chiu et al.
NEURON (2008)
Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD
Sungjin Park et al.
NEURON (2008)
Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome
Soong Ho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
On BC1 RNA and the fragile X mental retardation protein
Anna Iacoangeli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Advances on the understanding of the origins of synaptic pathology in AD
Pascale Nathalie Lacor
CURRENT GENOMICS (2007)
Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway
Matthew Townsend et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Intracellular amyloid-β in Alzheimer's disease
Frank M. LaFerla et al.
NATURE REVIEWS NEUROSCIENCE (2007)
A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability
Francesca Zalfa et al.
NATURE NEUROSCIENCE (2007)
Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
Fernanda G. De Felice et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
FMRP mediates mGluR5-dependent translation of amyloid precursor protein
Cara J. Westmark et al.
PLOS BIOLOGY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss
Helen Hsieh et al.
NEURON (2006)
Amyloid β peptide adversely affects spine number and motility in hippocampal neurons
Brikha R. Shrestha et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Insulin signaling in the central nervous system: Learning to survive
Lars P. van der Heide et al.
PROGRESS IN NEUROBIOLOGY (2006)
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Hilal A. Lashuel et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Temporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease -: A link between Aβ and tau pathology
S Oddo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ion channel formation by Alzheimer's disease amyloid beta-peptide (A beta 40) in unilamellar liposomes is determined by anionic phospholipids
JM Alarcon et al.
PEPTIDES (2006)
Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease
S Barghorn et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid β
MH Magdesian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of NMDA receptor trafficking by amyloid-β
EM Snyder et al.
NATURE NEUROSCIENCE (2005)
The role of metabotropic glutamate receptor 5 in learning and memory processes
A Simonyi et al.
DRUG NEWS & PERSPECTIVES (2005)
Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells
AD Douglass et al.
CELL (2005)
Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway
CC Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
DG Georganopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain
RH Takahashi et al.
JOURNAL OF NEUROSCIENCE (2004)
An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus
CC Huang et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5
QW Wang et al.
JOURNAL OF NEUROSCIENCE (2004)
Fasting insulin and incident dementia in an elderly population of Japanese-American men
R Peila et al.
NEUROLOGY (2004)
Synaptic targeting by Alzheimer's-related amyloid β oligomers
PN Lacor et al.
JOURNAL OF NEUROSCIENCE (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at Synapses
F Zalfa et al.
CELL (2003)
Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening
L Chang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus
HW Wang et al.
BRAIN RESEARCH (2002)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain
DM Walsh et al.
BIOCHEMISTRY (2000)
Intraneuronal A beta 42 accumulation in human brain
GK Gouras et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Understanding the molecular basis of fragile X syndrome
P Jin et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
